CorMedix (CRMD) Raw Materials (2019 - 2025)

CorMedix has disclosed Raw Materials across 5 years of filings, most recently posting $3.6 million for Q4 2025.

• Raw Materials for Q4 2025 came in at $3.6 million, up 227.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.6 million (up 227.18% YoY), and the FY2025 annual result was $3.6 million, up 227.18% from the prior year.
• Raw Materials came in at $3.6 million for Q4 2025 at CorMedix, down from $7.0 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $7.0 million in Q3 2025 to a low of $603545.0 in Q3 2024.
• The 3-year median for Raw Materials is $1.1 million (2025), against an average of $2.1 million.
• Across the five-year window, Raw Materials slipped 27.17% in 2024 and jumped 1062.75% in 2025, its largest moves.
• CorMedix's Raw Materials stood at $1.5 million in 2023, then decreased by 27.17% to $1.1 million in 2024, then soared by 227.18% to $3.6 million in 2025.
• The last three Raw Materials figures came in at $3.6 million (Q4 2025), $7.0 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.